Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Semin Radiat Oncol. 2014 Jul;24(3):181–191. doi: 10.1016/j.semradonc.2014.02.007

Fig 4.

Fig 4

MRI post-implant dosimetry in prostate phantom using C4 MRI markers within strands with I-125 dummy (i.e. non-radioactive) seeds. The positive contrast MRI markers facilitate the localization of the implanted negative contrast I-125 titatium seeds for post-implant MRI-based dosimetry.